Results 61 to 70 of about 59,070 (244)

Contribution of Gli1+ Adventitial Stem Cells to Smooth Muscle Cells in Atherosclerosis and Vascular Injury

Advanced Science, EarlyView.
Gli1+ adventitial stem cells (ASCs) have been thought to generate smooth muscle cells (SMCs) in atherosclerosis. Using a dual‐recombinase lineage tracing to exclude ectopic labeling, Wang et al. found that Gli1+ ASCs do not contribute to SMCs in atherosclerotic plaques.
Haixiao Wang, Xiuzhen Huang, Jialing Mou, Enci Wang, Yan Li, Wenjuan Pu, Yao Xie, Xiaoling Guo, Lixin Wang, Maoping Chu, Bin Zhou, Chao Niu   +11 more
wiley   +1 more source

Portal vein thrombosis after double installation of transjugular intrahepatic portosystemic stent (clinical observation)

Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
Relevance. Liver transplantation involves reconstruction of several vascular structures. Portal reconstruction presents many difficulties due to the frequent intraoperative detection of thrombosis.
M. S. Guska, A. D. Kuznetsova, B. I. Kazymov, K. F. Alekberov, Z. G. Kaziakhmedova, B. I. Yaremin   +5 more
doaj   +1 more source

Combination of Ethoxybenzyl‐Diethylenetriamine Pentaacetic Acid‐Enhanced Magnetic Resonance Imaging and a Serum Biomarker Is Useful in the Diagnosis of Hepatic Sinusoidal Disorder After Chemotherapy Treatment

Annals of Gastroenterological Surgery, EarlyView.
ROC analyses of APRI score, EOB‐MRI, and a combination of EOB‐MRI and APRI score for blue liver. ABSTRACT Aim Sinusoidal obstruction syndrome (SOS), also known as “blue liver (BL),” is a common hepatic injury following oxaliplatin‐based chemotherapy in patients with colorectal liver metastases (CRLM).
Tomonari Shimagaki, Keishi Sugimachi, Takahiro Tomino, Takeshi Kurihara, Emi Onishi, Yutaro Shimomura, Kenji Shinozaki, Masaru Morita   +7 more
wiley   +1 more source

Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis

Canadian Journal of Gastroenterology and Hepatology, 2021
Background and Aims. Portal vein thrombosis is a serious adverse event that occurs during liver cirrhosis. We performed a meta-analysis to evaluate the safety and efficacy of anticoagulant therapy and prophylactic anticoagulant therapy in cirrhosis ...
Huan Chen, Jiaming Lei, Sicheng Liang, Gang Luo, Mingming Deng, Muhan Lü   +5 more
doaj   +1 more source

Portal vein grafts in hepatic transplantation [PDF]

, 1985
Confirmation of patency of the portal vein by either ultrasound or angiography is a routine part of the evaluation of patients being considered for hepatic transplantation.
Bron, K, Iwatsuki, S, Shaw, BW, Starzl, TE   +3 more
core  

Elevated Risk of Complications in Patients Receiving Dual Antithrombotic Therapy Undergoing Hepatectomy: A Single‐Center Audit of 749 Cases

Annals of Gastroenterological Surgery, EarlyView.
This single‐center retrospective study evaluated perioperative outcomes after hepatectomy in 749 patients, including 140 receiving ATT, using propensity score matching to compare ATT and non‐ATT cohorts. Under standardized perioperative management, ATT did not increase major bleeding, transfusion, or severe morbidity overall; however, within the ATT ...
Haruki Mori, Hiromitsu Maehira, Nobuhito Nitta, Takeru Maekawa, Toru Miyake, Sachiko Kaida, Masatsugu Kojima, Katsushi Takebayashi, Takeshi Sonoda, Masaji Tani   +9 more
wiley   +1 more source

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. [PDF]

, 2018
It is common knowledge that cancer patients are more prone to develop venous thromboembolic complications (VTE). It is therefore not surprising that patients with hepatocellular carcinoma (HCC) present with a significant risk of VTE, with the portal vein
Burra, P, Campello, E, Russo, Fp., Simioni, P, Spiezia, L, Zanetto, A   +5 more
core   +1 more source

Robotic Versus Laparoscopic Anatomic Liver Resection: Comparison of Perioperative Outcomes—A Systematic Review and Meta‐Analysis

Annals of Gastroenterological Surgery, EarlyView.
Minimally invasive anatomic liver resection (AR) including major hepatectomy and liver parenchyma‐sparing AR is technically complex and demanding. This systematic review with meta‐analysis including 15 studies comparing 2042 robotic AR and 2129 laparoscopic AR patients demonstrated largely comparable perioperative outcomes and partly better outcomes ...
Yutaro Kato, Atsushi Sugioka, Hiroyuki Kato, Akihiko Horiguchi   +3 more
wiley   +1 more source

Portal Vein Thrombosis

Vascular Specialist International, 2011
Portal vein obstruction is a common finding at necropsy where it is usually related to cirrhosis or malignancy of abdominal organs. Noncirrhotic, nonmalignant portal vein thrombosis is uncommon. The main risk factors for noncirrhotic nonmalignant portal vein thrombosis are inflammatory foci in the abdomen, abdominal surgery (particularly splenectomy ...
openaire   +2 more sources

Portal Vein Thrombosis in a Patient with Type 1 Diabetes Presenting as Acute Pyelonephritis

European Journal of Case Reports in Internal Medicine, 2020
Background: Few cases have been reported with respect to portal vein thrombosis in non-cirrhotic patients. Asymptomatic or non-specific symptoms of portal vein thrombosis may lead to misdiagnosis or may delay the diagnosis until complications develop. We
Zahra Abdulwahed AL Saeed, Fatimah Mohammed Alabdrabalnabi, AlAnoud AlAnazi, Waleed Ibrahim Albaker, Osma Abdullah Al-Sultan   +4 more
doaj   +1 more source